Boothbay Fund Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-655
Closed -$3.1M 1828
2020
Q4
$3.1M Buy
655
+353
+117% +$16.4K 0.12% 163
2020
Q3
$1.41M Buy
302
+47
+18% +$1.61K 0.09% 326
2020
Q2
$920K Buy
+255
New +$9.39K 0.06% 416

Other funds holding ZYME

Boothbay Fund Management's ZYME Position: Q4 2025 in Review

Boothbay Fund Management sold out of Zymeworks (ZYME) in Q4 2025, closing a stake of 32,757 shares — an estimated $559K sold.

Boothbay Fund Management first reported a position in ZYME in Q2 2019 and held it in 3 quarters. The position peaked at $559K in Q3 2025. 209 funds tracked by Wall St. Rank hold ZYME as of Q4 2025.

  • Boothbay Fund Management reported no remaining Zymeworks position as of Q4 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 32,757 Zymeworks shares in Q4 2025, an estimated $559K.
  • Boothbay Fund Management first reported a position in Zymeworks in Q2 2019 and held it in 3 quarters.
  • Boothbay Fund Management's Zymeworks position peaked at $559K in Q3 2025.
  • 209 funds tracked by Wall St. Rank held Zymeworks as of Q4 2025.

Based on Boothbay Fund Management's 13F filing for Q4 2025, filed 17 Feb 2026.